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Ab stra ct
In tro duc tion: Peop le wi th meta bo lic syndro me are about twi ce as li ke ly to de ve lop ce reb ro vas cu lar di sea se (CVD) and over four ti mes as li ke ly to 
de ve lop type 2 dia be tes com pa red to sub jec ts wit hout me ta bo lic syndro me. This cro ss-sec tio nal po pu la tion ba sed stu dy was un der ta ken to explore 
the pre va len ce of me ta bo lic syndro me in a lo cal po pu la tion in In dia.
Ma te ria ls and met ho ds: The pre va len ce was as ses sed in a group of 1,568 pa tien ts re fer red to Hi gh Te ch Hos pi tal a:   lia ted to Vi naya ka Mis sio ns 
Uni ver si ty, Sa lem, In dia. We ha ve ana lyzed the ove ra ll pre va len ce of me ta bo lic syndro me, as we ll as the num ber of com po nen ts of the me ta bo lic 
syndro me pre se nt in the in di vi dua ls in this stu dy. For all sub jec ts fol lowi ng va riab les we re col lec ted: age, gen der, wai st cir cum fe ren ce, blood pres-
su re and fas ti ng cli ni cal che mis try pa ra me te rs. Blood pres su re was mo ni to red and mea su red in a sit ti ng po si tion by a mer cu ry sphygmo ma no me ter. 
Blood sam ples for HDL-cho les te rol, trig lyce ri de and fas ti ng glu co se we re col lec ted af ter 12h over nig ht fa st.
Re sul ts: In our group 33.17% of ma les and 27.04% of fe ma les we re iden ti G ed as ha vi ng the me ta bo lic syndro me. Wai st cir cum fe ren ce, dysli pi de mia 
and im pai red glu co se to le ran ce we re sig ni G  can tly mo re pre va le nt in our ma le sub jec ts than in fe ma les. Mul tip le lo gis tic reg res sion ana lysis showed 
that in crea si ng age (OR (95% CI) = 1.06 (1.040–1.070); P < 0.001) and ma le gen der (OR (95% CI) = 1.50 (1.190–1.890); P < 0.05) we re sig ni G  ca nt 
pre dic to rs of me ta bo lic syndro me in In dia.
Con clu sion: The me ta bo lic syndro me is substan tial ly pre va le nt in In dia. Its pre va len ce in creases wi th age and is hig her in men than in wo men. A 
fur ther stu dy is requi red to un der sta nd the ro le and in te r-re la tion ship be tween so me mo re and le ss known fac to rs pos sib ly as so cia ted wi th the me-
ta bo lic syndro me.
Key wor ds: dysli pi dae mia; me ta bo lic syndro me; pre va len ce; glu co se in to le ran ce; wai st cir cum fe ren ce
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In tro duc tion
Me ta bo lic syndro me (MS) al so known as syndro-
me X is cha rac te ri zed by hyper trig lyce ri dae mia 
and low con cen tra tion of hi gh den si ty li pop ro tein 
(HDL) cho les te rol (dysli pi de mia), ele va ted blood 
pres su re, im pai red glu co se to le ran ce and cen tral 
obe si ty (1). Peop le wi th MS are about twi ce as li ke-
ly to de ve lop ce reb ro vas cu lar di sea se (CVD) and 
over four ti mes as li ke ly to de ve lop type 2 diabe tes 
com pa red to sub jec ts wit hout me ta bo lic syndro-
me (2–4). It is we ll re cog ni zed that the syndro me 
has a ge ne tic ba sis alo ng wi th cer tain mo di Q ab le 
en vi ron men tal fac to rs (5,6). The pre se nt stu dy was 
un der ta ken to re po rt the pre va len ce of MS in the 
ci ty of Sa lem, lo ca ted in sout he rn pa rt of In dia.
Ma te ria ls and met ho ds
Sub jec ts
Patien ts who at ten ded the Hi gh Te ch Hos pi tal aX  -
lia ted to Vi naya ka Mis sio ns Uni ver si ty, Sa lem, In dia 
for rou ti ne me di cal che ckup for med the ca ses for 
the pre se nt cro ss-sec tio nal stu dy. The to tal of 
1,568 ca ses that re fer red to the hos pi tal du ri ng Ju-
ne 2007 to Septem ber 2009 was en rol led in to the 
stu dy. In for med con se nt was ta ken from all the 
sub jec ts.
Me ta bo lic syndro me was diag no sed ac cor di ng to 
the NCEP-ATP III cri te ria (Thi rd Re po rt of the Na tio-
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nal Cho les te rol Edu ca tion Prog ram Expe rt Pa nel 
on De tec tion, Eva lua tion and Treat me nt of Hi gh 
Blood Cho les te rol in Adul ts – Adu lt Treat me nt Pa-
nel III). Three or mo re of the fol lowi ng cri te ria for-
med the ba sis for de Q  ni ng me ta bo lic syndro me:
1. hyper ten sion, de fi ned as a his to ry of hyper ten-
sion or a blood pres su re grea ter than or equal 
to 130/85mm Hg;
2. hyper trig lyce ri dae mia, de fi ned as fas ti ng trig-
lyce ri des grea ter than or equal to 1.7 mmol/L;
3. hyper glycae mia, de fi ned as a his to ry of dia be-
tes or a fas ti ng blood glu co se grea ter than or 
equal to 5.60 mmol/L;
4. low HDL-cho les te rol, de fi ned as a fas ti ng HDL-
cho les te rol le ss than 1.00 mmol/L in men or le-
ss tha n 1.3 mmol/L in wo men; and
5. cen tral obe si ty, de fi ned as a wai st cir cum fe ren-
ce grea ter than 90 cen ti me te rs in Asian men 
or grea ter than 80 cen ti me te rs in Asian wo men 
(8,9).
Met ho ds
The fol lowi ng pa ra me te rs we re col lec ted: age, 
gen der, wai st cir cum fe ren ce, blood pres su re and 
fas ti ng cli ni cal che mis try pa ra me te rs. Blood pres-
su re was mo ni to red and measu red in a sit ti ng po-
si tion by a mer cu ry sphygmo ma no me ter (7). Blo-
od sam ples col lec ted af ter 12h over nig ht fa st we re 
ana lyzed to de ter mi ne the con cen tra tio ns of HDL-
cho les te rol, trig lyce ri de and fas ti ng glu co se usi ng 
Hi tac hi 901 Au toana lyzer (Roc he Diag nosti cs GmbH, 
Ger ma ny) (8).
Sta tis ti cal ana lysis
Da ta are pre sen ted as arit hme tic mean ± stan da rd 
de via tion. Stu de nt’s t-te st was used for com pa ri-
son of nu me ri cal va riab les. Chi-squa re te st was 
used to de ter mi ne the le vel of sig ni Q  can ce for ca-
te go ri cal variab les. Mul ti va ria te lo gis tic reg res sion 
was used to de Q  ne pre dic to rs of me ta bo lic syndro-
me. Va lues of P < 0.05 we re con si de red sta tis ti cal ly 
sig ni Q  ca nt.
Ana lysis was do ne usi ng SPSS sta tis ti cal sof twa re 
(Chi ca go, IL, USA).
Re sul ts
Out of 1,568 par ti cipan ts, the re we re 896 (56.8%) 
men and 672 (43.2%) wo men. Ten sub jec ts did not 
par ti ci pate in the stu dy. The mean age was 49 ± 13 
yea rs (age ran ge: 18–80 yea rs), ma les: 50 ± 60 yea-
rs; fema les: 53 ± 15 yea rs.
The de mog rap hic cha rac te ris ti cs of the po pu la-
tion are shown in Tab le 1. Ab do mi nal obe si ty, dy-
sli pi de mia and im pai red glu co se to le ran ce we re 
mo re pre va le nt in ma le sub jec ts than in the fe ma-
les. No ne of the stu died va riab les dij e red sig ni Q -
can tly be tween va rious age grou ps, wi th the ex-
cep tion of wai st ci rcum fe ren ce (Tab le 2). The pre-
va len ce of me ta bo lic syndro me was 33.17% in men 
and 27.04% in wo men (Tab le 3), the dij e ren ce was 
sta tis ti cal ly dij e re nt (P = 0.001).
Mul tip le lo gis tic reg res sion ana lysis showed that 







P (ma le vs. fe ma le)
Age (yea rs) 51 ± 15 53 ± 15 50 ± 16 < 0.001
Wai st cir cum fe ren ce (cm) 101.0 ± 10.2 105.0 ± 10.5 95.0 ± 9.5 < 0.001
Systo lic blood pres su re (mm Hg) 130.0 ± 12.5 130.0 ± 15 130.0 ± 10.0 0.859
Dias to lic blood pres su re (mm Hg) 77.0 ± 10.5 75.0 ± 7.5 80.0 ± 5.5 0.843
HDL-cho les te rol (mmol/L) 0.88 ± 0.20 0.95 ± 0.25 0.80 ± 0.15 < 0.001
Trig lyce ri de (mmol/L) 2.00 ± 0.93 1.85 ± 0.90 2.15 ± 0.95 < 0.001
Glu co se (mmol/L) 6.10 ± 0.70 6.15 ± 0.95 6.05 ± 0.45 0.006
TAB LE 1. De mog rap hic cha rac te ris ti cs of stu died po pu la tion.
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< 0.001) and ma le gen der (OR (95% CI) = 1.50 
(1.190–1.890); P < 0.05) we re sig ni Q  ca nt pre dic to rs 
of me ta bo lic syndro me.
Dis cus sion
The Na tio nal Cho les te rol Edu ca tion Prog ram 
(NCEP) Adu lt Treat me nt Pa nel (ATP) III de Q  ned the 
cri te ria for the diag no sis of me ta bo lic syndro me 
and laid down gui de li nes for its ma na ge me nt (8). 
In su lin re sis tan ce is re por ted to be the key com po-
ne nt for the clus te ri ng of ri sk fac to rs that lead to 
me ta bo lic syndro me (9).
In this cro ss-sec tio nal po pu la tion ba sed stu dy, 
33% of men and 27% of wo men we re diag no sed 
wi th the me ta bo lic syndro me. Our re sul ts show 
that the pre va len ce of MS ri ses wi th age. Al so, MS 
was mo re pre va le nt in men than in wo men. Asian 
In dia ns are known to ha ve lower bo dy ma ss in dex 
(BMI) than Eu ro pea ns (10). Howe ver, for any gi ven 
BMI, Asian In dia ns ha ve grea ter wai st-to-hip ra tios 
and ab do mi nal fat than Eu ro pea ns (11,12).
It wi ll be use ful to mea su re fac to rs as so cia ted wi th 
MS in dij e re nt po pu la tion to iden ti fy the pre va-
len ce of the syndro me and al so to es tab li sh whet-
her its pre va len ce dij e rs ac cor di ng to re gion, re li-
gion and li fe style (13). It wou ld be pos sib le to pre-
ve nt the ear ly precipi ta tion of dia be tes or car-
diovas cu lar even ts in a com mu ni ty by Q n di ng out 
the pre sen ce of me ta bo lic syndro me. This may he-
lp to es tab li sh ba sic gui de li nes of pre ven tion and 
cu re (14). It wi ll be the be st ap proa ch to for mu la te 
a heal th po li cy at a com mu ni ty le vel to pro vi de 
heal th ca re and al so edu ca te the me di cal gra dua-
tes to un der sta nd the ba sic heal th nee ds of the 
com mu ni ty they ser ve.






> 60 yea rs
(N = 198)
P (ANOVA)
Age (yea rs) 36 ± 5 49 ± 6 53 ± 6 65 ± 9
Wai st cir cum fe ren ce (cm) 82.5 ± 8.5 102.5 ± 8.75 102.5 ± 5.0 84.0 ± 5.5 < 0.05
Systo lic blood pres su re (mm Hg) 128 ± 4.5 132 ± 5.0 135 ± 4.5 130 ± 5.5 0.859
Dias to lic blood pres su re (mm Hg) 80 ± 3.5 85 ± 5.5 85 ± 5.5 82.5 ± 4.5 0.843
HDL-cho les te rol (mmol/L) 1.05 ± 0.10 0.95 ± 0.15  0.85 ± 0.15 0.90 ± 0.20 0.842
Trig lyce ri de (mmol/L) 1.7 ± 0.40 2.0 ± 0.30 2.05 ± 0.20 2.00 ± 0.25 0.838
Glu co se (mmol/L) 6.05 ± 0.45 6.10 ± 0.50 6.20 ± 0.45 6.10 ± 0.50 0.861






P (ma le vs. fe ma le)
Total
N (%)
Num ber of com po ne nts
1 211 (24.7%) 192 (30.7%) 0.054 403 (25.63%)
2 186 (21.85) 109 (17.4%) 0.069 295 (18.69%)
3 162 (18.9%) 99 (15.8%) 0.052 261 (16.47%)
4 88 (10.3%) 53 (8.48%) 0.138 141 (8.93%)
5 33 (3.85) 17(2.72%) 0.138 50 (3.16%)
Me ta bo lic syndro me 283 (33.17%) 169 (27.04%) 0.001 452 (28.14%)
TAB LE 3. Pre va len ce of com po nen ts of me ta bo lic syndro me.
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Pre va len ci ja me ta boličkog sin dro ma kod lo kal ne po pu la ci je u In di ji
Sažetak
Uvod: Oso be s me ta bo ličkim sin dro mom ima ju dvos tru ko veći ri zik od raz vo ja ce reb ro vas ku lar nih bo les ti te više od četi ri pu ta veći ri zik od raz-
vo ja šećer ne bo les ti ti pa 2 u us po red bi s oso ba ma bez metabo ličkog sin dro ma. Ovo pres ječno po pu la cij sko is traživa nje je pro ve de no ka ko bi se 
is tražila pre va len ci ja me ta bo ličkog sin dro ma kod lo kal ne po pu la ci je u In di ji.
Ma te ri ja li i me to de: Pre va len ci ja me ta bo ličkog sin dro ma ut vrđena je u sku pi ni od 1.568 bo les nika ko ji su upućeni u bol ni cu u sklo pu Sveu-
čilišta Vi naya ka Mis sio ns, Sa lem, In di ja. Is pi ta na je uku pna pre va len cija, kao i broj sas tav ni ca me ta bo ličkog sin dro ma pri sut nih kod is pi ta ni ka. 
Pri kup lje ni su po da ci o slje dećim va ri jab la ma: dob, spol, op seg struka, kr vni tlak i bio ke mij ski pa ra met ri na tašte. Kr vni tlak je iz mje ren u sje-
dećem po ložaju živi nim tla kom je rom. Uzor ci kr vi za od ređiva nje kon cen tra ci je HDL ko les te ro la, trig li ce ri da i glu ko ze na tašte uze ti su ujut ro na kon 
12-osatnog pos ta.
Re zul ta ti: U našoj smo sku pi ni ot kri li da 33,17% muška ra ca i 27,04% žena ima me ta bo lički sin drom. Pre va len ci ja opsega stru ka, dis li pi de mije i 
oštećenog pod nošenja glu ko ze bi le su sta tis tički značaj no veća kod muških is pi ta ni ka ne go kod žena. Ana li za višes tru ke lo gis tičke reg re si je po ka-
za la je da su sta ri ja dob (OR (95% CI) = 1,06 (1,040–1,070); P < 0.001) i muški spol (OR (95% CI) = 1,50 (1,190–1,890); P < 0.05) značaj ni pred ska-
za te lji me ta bo ličkog sin dro ma u In di ji.
Zak ljučak: Me ta bo lički sin drom je u In di ji pri su tan u znat noj mje ri. Nje go va pre va len ci ja ras te sa do bi te je veća kod muška ra ca ne go kod žena. 
Pot reb na su dalj nja is traživa nja ka ko bi se ra zum je la ulo ga međusob ne po ve za nos ti iz među ne kih dob ro poz na tih i ne kih ma nje poz na tih čim be-
ni ka ko ji bi mog li bi ti po ve za ni s me ta bo ličkim sin dro mom.
Ključne ri ječi: dis li pi de mi ja; me ta bo lički sin drom; pre va len ci ja; ne to le ran ci ja glu ko ze; op seg struka
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